Clinical Trial Update: Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers [Phase 3]

View source ↗

Summary

Phase 3 study evaluating a booster injection of Pentaxim vaccine administered with a dengue vaccine in healthy toddlers has completed with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dengue
• Dengue Hemorrhagic Fever

Drugs mentioned

• Pentaxim

Snippet

Sponsor: Sanofi Pasteur, a Sanofi Company | Conditions: Dengue, Dengue Hemorrhagic Fever | Phase 3 | Status: COMPLETED | Results posted: 2019-07-29